Screener / SEC EDGAR /CIK 0001795586 /Numbers from the XBRL of the 10-Ks
Nasdaq Financials · Financial Services

Chime Financial, Inc. CHYM

Compare with peers Embed
Planned sales, announced before they happen

9 trading plans running, 48 Form 144 notices for $125.4M

10-Q, 10-K and Form 144
Plans running now 9 Christopher Britt, Ryan King, Amine Asmerom, Mark Troughton, Adam Frankel, Matthew Newcomb
Plans adopted 12 reported since Aug 11, 2025 Form 144 notices 48 $125.4M the sellers expected to sell

What CHYM's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Aug 28, 2025 to Jan 6, 2028. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Christopher Britt
Chief Executive Officer and the chairman of our Board of Directors
Adopted 10b5-1 plan Sep 16, 2026 10-Q Nov 5, 2026
What the company wrote
On September 16, 2026, Christopher Britt, our Chief Executive Officer and the chairman of our Board of Directors, through the Britt Living Trust, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 1,750,000 shares of our Class A common stock on or prior to December 17, 2027. This trading arrangement will not commence until the expiration of Mr. Britt’s previous trading arrangement by its terms on December 5, 2026.
Ryan King
Co-Founder and a member of our Board of Directors
Adopted 10b5-1 plan Sep 16, 2026 10-Q Nov 5, 2026
What the company wrote
On September 16, 2026, Ryan King, our Co-Founder and a member of our Board of Directors, through the King Family Trust, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 2,250,000 shares of our Class A common stock on or prior to January 6, 2028. This trading arrangement will not commence until the expiration of Mr. King’s previous trading arrangement by its terms on January 5, 2027.
Amine Asmerom
Chief Accounting Officer
Adopted 10b5-1 plan Sep 11, 2026 10-Q Nov 5, 2026
What the company wrote
On September 11, 2026, Amine Asmerom, our Chief Accounting Officer, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 79,913 shares of our Class A common stock on or prior to June 15, 2027.
Mark Troughton
President and Interim Chief Financial Officer
Adopted 10b5-1 plan Sep 11, 2026 10-Q Nov 5, 2026
What the company wrote
On September 11, 2026, Mark Troughton, our President and Interim Chief Financial Officer, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 750,000 shares of our Class A common stock on or prior to May 31, 2027.
Adam Frankel
General Counsel
Adopted 10b5-1 plan Jun 16, 2026 10-Q Aug 6, 2026
What the company wrote
On June 16, 2026, Adam Frankel, our General Counsel, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 247,329 shares of our Class A common stock on or prior to March 31, 2027.
Amine Asmerom
Chief Accounting Officer
Adopted 10b5-1 plan Jun 9, 2026 10-Q Aug 6, 2026
What the company wrote
On June 9, 2026, Amine Asmerom, our Chief Accounting Officer, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 39,505 shares of our Class A common stock on or prior to March 15, 2027. This trading arrangement will not commence until the expiration of Mr. Asmerom’s previous trading arrangement by its terms on September 6, 2026.
Amine Asmerom
Chief Accounting Officer
Adopted 10b5-1 plan Dec 4, 2025 10-K Mar 6, 2026
What the company wrote
On December 4, 2025, Amine Asmerom, our Chief Accounting Officer, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 39,505 shares of our Class A common stock on or prior to September 6, 2026.
Christopher Britt
Chief Executive Officer and the chairman of our Board of Directors
Adopted 10b5-1 plan Sep 15, 2025 10-Q Nov 10, 2025
What the company wrote
On September 15, 2025, Christopher Britt, our Chief Executive Officer and the chairman of our Board of Directors, through the Britt Living Trust, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 1,000,000 shares of our Class A common stock, including certain shares held by his spouse, on or prior to December 5, 2026.
Adam Frankel
General Counsel
Adopted 10b5-1 plan Sep 8, 2025 10-Q Nov 10, 2025
What the company wrote
On September 8, 2025, Adam Frankel, our General Counsel, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 199,986 shares of our Class A common stock on or prior to June 1, 2026.
Ryan King
Co-Founder and a member of our Board of Directors
Adopted 10b5-1 plan Aug 28, 2025 10-Q Nov 10, 2025
What the company wrote
On August 28, 2025, Ryan King, our Co-Founder and a member of our Board of Directors, through the King Family Trust, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 1,625,000 shares of our Class A common stock on or prior to January 5, 2027.
Matthew Newcomb
Chief Financial Officer
Adopted 10b5-1 plan Aug 25, 2025 10-Q Nov 10, 2025
What the company wrote
On August 25, 2025, Matthew Newcomb, our Chief Financial Officer, through the 2019 Newcomb Fox Family Trust, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 600,000 shares of our Class A common stock on or prior to November 24, 2026.
Amine Asmerom
Chief Accounting Officer
Adopted 10b5-1 plan Aug 19, 2025 10-Q Nov 10, 2025
What the company wrote
On August 19, 2025, Amine Asmerom, our Chief Accounting Officer, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act pursuant to which he may sell up to 94,491 shares of our Class A common stock on or prior to November 15, 2026.
Show the other 4 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 6 filings checked since Aug 11, 2025.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 13, 2026 CROSSLINK CROSSOVER FUND VII, LP
Director
36,000 $1.2M
Nov 13, 2026 CROSSLINK CROSSOVER FUND VI, LP
Director
64,000 $2.1M
Oct 13, 2026 KING FAMILY TRUST
Director, Officer
75,000 $2.3M
Oct 9, 2026 KING FAMILY TRUST
Director, Officer
50,000 $1.4M
Sep 16, 2026 CROSSLINK CROSSOVER FUND VII, LP
Director
54,600 $1.7M
Sep 16, 2026 CROSSLINK CROSSOVER FUND VI, LP
Director
95,400 $3.0M
Sep 16, 2026 CROSSLINK VENTURES VII HLDGS, LLC
Director
161,437 $5.3M
Sep 15, 2026 ADAM B FRANKEL
Officer
102,002 $3.5M
Sep 15, 2026 CROSSLINK CROSSOVER FUND VII, LP
Director
54,600 $1.8M
Sep 15, 2026 CROSSLINK CROSSOVER FUND VI, LP
Director
95,400 $3.2M
Sep 14, 2026 CROSSLINK CROSSOVER FUND VI, LP
Director
95,400 $3.3M
Sep 14, 2026 CROSSLINK CROSSOVER FUND VII, LP
Director
54,600 $1.9M
Sep 11, 2026 CYNTHIA MARSHALL
Director
20,000 $662K
Sep 11, 2026 CROSSLINK CROSSOVER FUND VII, LP
Director
55,692 $1.8M
Sep 11, 2026 CROSSLINK CROSSOVER FUND VI, LP
Director
97,308 $3.2M
Sep 10, 2026 CROSSLINK CROSSOVER FUND VII, LP
Director
53,508 $1.8M
Sep 10, 2026 CROSSLINK CROSSOVER FUND VI, LP
Director
93,492 $3.1M
Sep 10, 2026 Menlo Inflection II, L.P. (fka Menlo Special Opportunities Fund II, L.P.)
Shareholder
569,755 $19.7M
Sep 10, 2026 Menlo Entrepreneurs Inflection Fund, L.P.
Shareholder
3,765 $130K
Sep 10, 2026 MM Inflection, L.P.
Shareholder
5,793 $200K
Sep 9, 2026 KING FAMILY TRUST
Director, Officer
42,421 $1.4M
Sep 9, 2026 2019 NEWCOMB FOX FAMILY TRUST
Officer
42,420 $1.4M
Sep 8, 2026 AMINE ASMEROM
Officer
19,505 $658K
Aug 28, 2026 BRITT LIVING TRUST
Director, Officer
300,000 $10.0M
Aug 28, 2026 BRITT LIVING TRUST
Director, Officer
300,000 $10.0M
Aug 24, 2026 2019 NEWCOMB FOX FAMILY TRUST
Officer
25,000 $820K
Aug 10, 2026 BRITT LIVING TRUST
Director, Officer
150,000 $4.4M
Aug 7, 2026 BRITT LIVING TRUST
Director, Officer
117,000 $3.7M
Aug 6, 2026 2019 NEWCOMB FOX FAMILY TRUST
Officer
65,000 $1.7M
Aug 6, 2026 KING FAMILY TRUST
Director, Officer
375,000 $9.7M
Aug 6, 2026 AMINE ASMEROM
Officer
10,000 $259K
Aug 6, 2026 ALEXANDRA BRITT
Member of immediate family of any of the foregoing
283,000 $7.3M
Aug 4, 2026 AMINE ASMEROM
Officer
10,000 $243K
Jun 15, 2026 ADAM B FRANKEL
Officer
3,000 $52K
Jun 9, 2026 ADAM B FRANKEL
Officer
3,000 $54K
Mar 2, 2026 CYNTHIA MARSHALL
Director
35,000 $780K
Jan 9, 2026 ALEXANDRA BRITT
Member of immediate family of any of the foregoing
50,000 $1.4M
Jan 9, 2026 ADAM FRANKEL
Officer
500 $14K
Jan 9, 2026 2019 NEWCOMB FOX FAMILY TRUST
Officer
10,000 $277K
Jan 8, 2026 ADAM FRANKEL
Officer
4,382 $119K
Dec 16, 2025 CROSSLINK CROSSOVER FUND VII, LP
Director
4,571 $113K
Dec 16, 2025 CROSSLINK CROSSOVER FUND VI, LP
Director
7,229 $179K
Dec 11, 2025 CROSSLINK CROSSOVER FUND VI, LP
Director
176,168 $4.8M
Dec 11, 2025 CROSSLINK CROSSOVER FUND VII, LP
Director
111,393 $3.0M
Dec 11, 2025 ADAM FRANKEL
Officer
500 $13K
Dec 10, 2025 ADAM FRANKEL
Officer
1,000 $24K
Dec 8, 2025 ADAM FRANKEL
Officer
6,760 $163K
Nov 26, 2025 AMINE ASMEROM
Officer
84,589 $1.7M
Show the other 40 notices

From the Form 144 XML filed with the SEC, since Nov 26, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CHYM/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.